Results of pediatric study present new questions.
Parks
V E
VE
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011787:Quality of Health Care; D015215:Zidovudine / Q000008:administration & dosage
D015215:Zidovudine; D016049:Didanosine